Figure 3 | Scientific Reports

Figure 3

From: The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study

Figure 3

Repigmentation outcome in non-segmental vitiligo, both lower leg lesions. (A)  Placebo group: (A0) baseline, (A3) 3 months, (A6) 6 months, (AF2) 2 months follow-up. (B)  Bimatoprost monotherapy group: (B0) baseline, (B3) 3 months, (B6) 6 months, (BF2) 2 months follow-up. (C)  Combination therapy: (C0) baseline, (C3) 3 months, (C6) 6 months, (CF2) 2 months follow-up.

Back to article page